Taro Pharmaceutical Industries Ltd (TARO.N)
17 Apr 2014
|Market Cap (Mil.):||$4,698.71|
|Shares Outstanding (Mil.):||44.79|
MUMBAI - Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.
Reuters Market Eye - Sun Pharmaceutical Industries gains 1 percent after unit Taro Pharmaceutical Industries announced the start of a tender offer to buy back up to $200 million of its ordinary shares.
* India's Sun Pharmaceutical Industries Ltd gains 1 percent after unit Taro Pharmaceutical Industries announced the start of a tender offer to buy back up to $200 million of its ordinary shares. * If the offer is fully subscribed, the number of Taro shares to be purchased in the offer represents approximately 4.6 to 5.3 percent of the unit's total outstanding shares. * Sun Pharma's stake in Taro will go up to more than 69 percent from 66 percent should the buyback be fully subscribed. (abhi
BRIEF-Bluemountain Capital Management and Iszo Capital file lawsuit against Taro Pharmaceutical Industries
Nov 21 - BlueMountain Capital Management: * Bluemountain Capital Management and Iszo Capital file lawsuit against Taro
Reuters Markete Eye - Sun Pharmaceutical Industries Ltd gains 2.8 percent after its unit Taro Pharmaceutical Industries Ltd operational earnings beat some analysts estimates.
* India's Sun Pharmaceutical Industries Ltd gains 3 percent after its unit Taro Pharmaceutical Industries Ltd operational earnings beat some analysts estimates. * Taro's quarterly earnings per share came at $2.15 while sales rose 27.5 percent to $205.3 million. * Analysts say a price hike in certain product categories by Taro led to the operating earnings beat while also boosting outlook for Sun Pharmaceutical's earnings results later in the day. (firstname.lastname@example.org /; abhis
|Ranbaxy Laboratories Limited (RANB.NS)||Rs468.45||+2.35|
|Pfizer Inc. (PFE.N)||$30.25||+0.16|
|Novartis AG (NOVN.VX)||CHF74.70||+0.35|
|Merck & Co., Inc. (MRK.N)||$56.47||+0.21|
|Bayer AG (BAYGn.DE)||€93.59||+0.66|
|Bayer AG (BAYE.F)||--||--|
|GlaxoSmithKline plc (GSK.L)||1,559.00p||-4.50|
|Eli Lilly and Co (LLY.N)||$60.43||+0.47|
|Teva Pharmaceutical Industries Limited (TEVA.TA)||17,330.00₪||-120.00|
|Bristol-Myers Squibb Co (BMY.N)||$49.46||+0.35|